Current status of the monitoring of medication practice

American Journal of Health-System Pharmacy

Volumn 66, Issue 5 SUPPL. 3, 2009, Pages

  Cousins, David ^a  

^a NATIONAL PATIENT SAFETY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CLINICAL PHARMACY; CONFERENCE PAPER; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HUMAN; MEDICATION ERROR; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; DRUG THERAPY; HEALTH CARE QUALITY; HOSPITAL PHARMACY; OUTCOME ASSESSMENT; REVIEW; SELF EVALUATION;

DRUG THERAPY; HUMANS; MEDICATION ERRORS; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PHARMACY SERVICE, HOSPITAL; QUALITY ASSURANCE, HEALTH CARE; SELF ASSESSMENT (PSYCHOLOGY);

EID: 63049099334     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080605     Document Type: Conference Paper

References (84)

1. Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q. 2005; 83:691-729.
2. Shaw C. External assessment of health care. BMJ. 2001; 322:851-4.
3. Montagu D. Accreditation and other external quality assessment systems for healthcare. Review of experience and lessons learned. DFID Health Systems Resource Centre. www.dfidhealthrc.org/publications/health-service-delivery/ Accreditation.pdf (accessed 2008 Dec 2).
4. Joint Commission Resources. Joint Commission International accreditation standards for hospitals, 3rd Edition. www.jcrinc.com/Accreditation-Manuals/JCI- ACCREDITATION-STANDARDS-FOR-HOSPITALS-THIRD-EDITION/1409/ (accessed 2008 Dec 2).
5. The Institute for Safe Medication Practice. 2004 ISMP Medication Safety Self Assessment for Hospitals. www.ismp.org/selfassessments/Hospital/Intro.asp (accessed 2008 Dec 2).
6. Smetzer JL, Vaida AJ, Cohen MR et al. Findings from the ISMP medication safety self assessment for hospitals. Jt Comm J Qual Saf. 2003; 29:586-95.
7. Lesar T, Mattis A, Anderson E et al. Using the ISMP Medication safety self-assessment to improve medication use processes. Jt Comm J Qual Saf. 2003; 29:211-26.
8. Clinical Excellence Commission. Medication safety self-assessment for Australian hospitals. https://mssa.cec.health.nsw.gov.au/index-files/MSSA.pdf (accessed 2008 Dec 2).
9. Institute for Safe Medication Practice. Medication safety self-assessment for hospitals (Canadian version II). www.ismp-canada.org/hinssa/index.htm (accessed 2008 Dec 2).
10. American Society of Health-System Pharmacists. Best practice self-assessment tool. www.ashp.org/s-ashp/docs/files/2015- self%20Assessment%20Tool-May%202008.pdf (accessed 2009 Jan 16).
11. Nelson SP, Abramowitz PW. Using ASHP best practice self-assessment tools. Am J Health-Syst Pharm. 2004; 61:562-3.
12. International Pharmaceutical Federation. Good pharmacy practice. Standards for quality of pharmacy services. www.fip.org/www/index.php?page=menu- goodpharmacypractice (accessed 2008 Dec 2).
13. International Pharmaceutical Federation. Good pharmacy practice (GPP) in developing countries. Recommendations for step-wise implementation. www.fip.org/files/fip/Statements/latest/Dossier%20003%20total.PDF (accessed 2008 Dec 2).
14. Camp RC, Tweet AG. Benchmarking applied to health care. Jt Comm J Qual Improv. 1994; 20:229-38.
15. Murphy IE. Using benchmarking data to evaluate and support pharmacy programs in health systems. Am J Health-Syst Pharm. 2000; 57(suppl 2):S28-31.
16. New South Wales Advisory Group. Indicators for Quality Use of Medicines in Australian Hospitals. www.ciap.health.nsw.gov.au/nswtag/indicators.html (accessed 2009 Ian 11).
17. Healthcare Commission. The best medicine: the management of medicines in acute and specialist trusts. www.healthcarecommission.org.uk/-db/-documents/The- Best-Medicine-acute-trust-tagged.pdf (accessed 2009 Ian 16).
18. MacDougal C, Polk RE. Variability in rates of antibacterials amongst 130 US hospitals and risk-adjustment models for interhospital comparison. Infect Control Hosp Epidemiol. 2008; 29:203-11.
19. Knoer SI, Couldry RJ, Folker T. Evaluating a benchmarking database and identifying cost reduction opportunities by diagnosis-related group. Am J Health-Syst Pharm. 1999; 56:1102-7.
20. Hiom S, Roberts D, Hawksbee M et al. Benchmarking the current dispensing rate of Welsh hospital pharmacies. J Clin Pharm Ther. 2006; 31:357-62.
21. Bond CA, Raehl CL. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Pharmacotherapy. 2008; 28(1):1-13.
22. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP National Survey of pharmacy practice in hospital settings: prescribing and transcribing-2007. Am J Health-Syst Pharm. 2008; 65:827-43.
23. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP National Survey of pharmacy practice in hospital settings: monitoring and patient education-2006. Am J Health-Syst Pharm. 2007; 64:507-20.
24. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP National Survey of pharmacy practice in hospital settings: dispensing and administration 2005. Am J Health-Syst Pharm. 2006; 63:327-45.
25. Wilson SG, Tsui M, Tong N et al. Hospital pharmacy service provision in Australia-1998. Am J Health-Syst Pharm. 2000; 57:677-680.
26. European Association of Hospital Pharmacists. Survey of Hospital Practice 2005. www.eahp.eu/EJHP/EJHP-Practice/Issue-3-2005/2005-EAHP-Survey/The-pratice- of-hospital-pharmacy-in-Europe-3rd-EAHP-European-survey (accessed 2009 Jan 16).
27. LeBlanc JM, Seoane-Vazquez E, Dasta JF. Survey of hospital pharmacist activities outside of the United States. Am J Health-Syst Pharm. 2007; 64:1748-55.
28. Agency for Healthcare Research and Quality. Surveys and tools to advance patient-centered care. Consumer assessment of healthcare providers and systems. www.cahps.ahrq.gov (accessed 2008 Dec 11).
29. Agency for Health Care Policy and Research, Lewin Group. The outcome of outcomes research at AHCPR; final report. www.ahrq.gov/clinic/outcosum.htm (accessed 2008 Dec 11).
30. Agency for Healthcare Research and Quality. Outcomes research fact sheet. www.ahrq.gov/clinic/outfact.htm (accessed 2008 Dec 11).
31. Kaboli PJ, Hoth AB, McClimon BJ et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006; 166:955-64.
32. De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy intervention. A literature review. Am J Health-Syst Pharm. 2008; 65:1161-72.
33. Dooley MJ, Allen KM, Doecke CJ et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government hospitals. Br J Clin Pharmacol. 2004; 57:513-21.
34. Spinewine A, Dhillon S, Mallet L et al. Implementation of ward-based clinical pharmacy services in Belgium -description of the impact on a geriatric unit. Ann Pharmacother. 2006; 40:720-8.
35. Raybardhans S, Balen RM, Partovi N et al. Documenting drug related problems with personal digital assistants in a multisite health system. Am J Health-Syst Pharm. 2005; 62:1782-7.
36. Allenet B, Bedouch P, Rose FX et al. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci. 2006; 28:181-8.
37. Bosma L, Jansman FG, Franken AM. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008; 30:31-8.
38. Barber ND, Batty R, Ridout DA. Predicting the rate of physician accepted interventions by hospital pharmacist in the United Kingdom. Am J Health-Syst Pharm. 1997; 54:397-405.
39. Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005; 14:207-11. [Erratum, Qual Saf Health Care. 2005; 14:312.]
40. Galindo C, Olive M, Lacasa C et al. Pharmaceutical care: pharmacy involvement in prescribing in an acute care hospital. Pharm World Sci. 2003; 25:56-84.
41. Millar T, Sandilya R, Tordoff J et al. Documenting pharmacists clinical interventions in New Zealand Hospitals. Pharm World Sci. 2008; 30:99-106.
42. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006; 26:735-47.
43. Chan FW, Wong RS, Lau WH et al. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial. Br J Clin Pharmacol. 2006; 62:601-9.
44. Burns N. Evaluation of warfarin dosing by pharmacists for elderly medical inpatients. Pharm World Sci. 2004; 26:232-7.
45. Tonna AP, Stewart D, West B et al. Antimicrobial optimisation in secondary care: the pharmacist as part of a multi-disciplinary antimicrobial programme-a literature review. Int J Antimicrob Agents. 2008; 31:511-7.
46. Von Gunten V, Reymond JP, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci. 2007; 29:146-63.
47. Koshman SL, Charrois TL, Simpson SH et al. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008; 168:687-94.
48. Machado M, Bajcar J, Guzzo GC et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007; 41:1569-82.
49. Machado M, Bajcar J, Guzzo GC et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007; 41:1770-81.
50. Ponniah A, Anderson B, Shakib S et al. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007; 32:343-52.
51. Zaidi ST, Hassan Y, Postma MJ et al. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian Hospital. Pharm World Sci. 2003; 25:299-302.
52. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008; 28:421-36.
53. Foisy MM, Akai PS. Pharmaceutical care for HIV patients on directly observed therapy. Ann Pharmacother. 2004; 38:550-6.
54. Sanghera N, Chan PY, Khaki ZF et al. Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug Saf. 2006; 29:1031-47.
55. Touw DJ, Neef C, Thomson AH et al. Cost-effectiveness of therapeutic drug monitoring: an update. EJHP. 2007; 13:83-91.
56. National Coordinating Council for Medication Error Reporting and Prevention. About medication errors. What is a medication error? www.nccmerp.org/aboutMedErrors.html (accessed 2008 Dec 11).
57. World Health Organisation. Safety of medicines. A guide to detecting and reporting adverse drug reactions. Why health professionals need to take action. http://whqlibdoc.who.int/hq/2002/WHO-EDM-QSM-2002.2.pdf (accessed 2008 Dec 11).
58. Bates DW, Boyle DL, Vander Vliet MB et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995; 10:199-205.
59. Morimoto T, Gandhi TK, Seger AC et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004; 13:306-14.
60. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 277:301-6.
61. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993; 8:289-94.
62. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995; 274:29-34.
63. Kanjanarat P, Winterstein AG, Johns TE et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health-Syst Pharm. 2003; 60:1750-9.
64. Council of Europe. Expert Group on Safe Medication Practices. Creation of a better medication safety culture in Europe: building up safe medication practices. www.coe.int/t/e/social-cohesion/soc-sp/ Medication%20Safety%20culture%20 report%20E.pdf (accessed 2009 Jan 16).
65. Terzibanjan AR, Laaksonen R, Weiss M et al. Medication error reporting systems-lessons learnt: executive summary of the findings. www.fip.org/files/ fip/Pat ient%20Safety/Medication%20Error%20Reporting%20-%20Lessons%20Learnt2008. pdf (accessed 2009 Jan 16).
66. Resar RK, Rozich JD, Classen D. Methodology and rationale for the measurement of harm with trigger tools. Qual Saf Health Care. 2003; 12(suppl 2):ii39-ii45.
67. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003; 12:194-200.
68. Cohen MM, Kimmel NL, Benage MK et al. Medication safety program reduces adverse drug events in a community hospital Qual Saf Health Care. 2005; 14:169-174.
69. Beso A, Franklin BD, Barber N. The frequency and potential causes of dispens ing errors in a hospital pharmacy. Pharm World Sci. 2005; 27:182-90.
70. Cina JL, Gandhi TK, Churchill W et al. How many hospital pharmacy medication dispensing errors go undetected? Jt Comm J Qual Patient Saf. 2006; 32:73-80.
71. Poon EG, Cina JL, Churchill W et al. Medication dispensing errors before and after implementing bar code technology in the pharmacy. Arch Intern Med. 2006; 145:426-34.
72. Roberts DE, Spencer MG, Burfield R et al. An analysis of dispensing errors in UK hospitals. Int J Pharm Pract. 2002; 10:R6.
73. Rolland P. Occurrence of dispensing errors and efforts to reduce medication errors at the Central Arkansas Veteran's Healthcare System. Drug Saf. 2004; 27:271-82.
74. Spencer MG, Smith AP. A multicentre study of dispensing errors in UK hospitals. Int J Pharm Pract. 1993; 2:142-6.
75. Lazarou J, Pomeranz BH, Corey PN. Incidence of ADR in hospitalised patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1000-5.
76. Moore N, Lecointre D, Noblet C et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol. 1998; 45:301-8.
77. White TJ, Arakelian A, Rho JP. Counting the cost of drug related adverse events. Pharmacoeconomics. 1999; 15:445-58.
78. Ferner RE, Aronson JK. National differences in publishing papers on adverse drug reactions. Br J Clin Pharmacol. 2005; 59:108-11.
79. Temple ME, Robinson RF, Miller JC et al. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf. 2004; 27:819-29.
80. Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2008; 65:210-6.
81. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmcol Res. 2006; 54:226-33.
82. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008; 102:408-11.
83. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol. 2007; 34:494-8.
84. The Basel Statements on the future of hospital pharmacy Am Soc Health-Syst Pharm. 2009; 66(suppl 3):S61-6.